A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)

Clinical trial NCT07547787 · RECRUITING

Trial details

NCT number: NCT07547787
Sponsor: Akeso
Status: RECRUITING
Study type: OBSERVATIONAL

Locally Advanced Unresectable or Metastatic Gastric Cancer

Start date: 2024-12-26
Primary completion: 2030-12-31
Enrollment: 610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.